Specific attributes of an API that can affect its suitability for inhalation delivery include its physicochemical and interfacial properties, the ease and robustness of its manufacturing process, its ...

The Company is utilising this proprietary manufacturing technology to produce its primary drug target, the psilocybin-based KRN-101. VANCOUVER — Albert Labs International Corp., a pharmaceutical ...

The rise of pharmaceutical continuous manufacturing (PCM), which is often supported by process analytical technology (PAT), has improved the safety, quality, efficacy, consistency, and purity of ...

The global biotech API manufacturing services market, valued at US$ 38.9 Bn in 2022, is anticipated to grow at a CAGR of 7.1% and exceed US$ 73 Bn by 2031. Factors such as increasing demand for ...

Inhalation formulations are complex, and empirical data are essential for realizing optimal solutions. Inhaled drug formulation involves consideration of multiple factors, including the properties of ...